Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Helmut Hund is a privately held German technology and instrument manufacturer headquartered in Wetzlar. The company develops and manufactures products spanning microscopy, pollen monitoring, dust monitoring, and lateral-flow test reading, while also serving as an OEM and contract development/manufacturing partner in electronics, optics, fiber optics, plastics technology, and precision engineering. Its healthcare relevance comes primarily from microscopy for medical and laboratory use and from the LFT 100 lateral-flow reader for point-of-care diagnostics. Helmut Hund does not appear to be a therapeutics biotech or pharmaceutical developer; rather, it is a commercial-stage medtech and scientific instrumentation company with cross-sector activity in medical technology, environmental measurement, industrial measurement, automation, and sensor technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Helmut Hund.